Patent Armory Inc. v. AdaptHealth: Call Routing Patent Dismissed in Just Seven Days
What would you like to do next?
Choose your path based on your current needs:
📋 Case Summary
| Case Name | Patent Armory Inc. v. AdaptHealth Patient Care Solutions LLC |
| Case Number | 2:25-cv-03443 (E.D. Pa.) |
| Court | U.S. District Court for the Eastern District of Pennsylvania |
| Duration | Jul 2025 – Jul 2025 7 days |
| Outcome | Plaintiff Voluntary Dismissal (Without Prejudice) |
| Patents at Issue | |
| Accused Products | Intelligent communication routing systems, entity matching, and telephony control systems |
Case Overview
The Parties
⚖️ Plaintiff
A patent assertion entity with a history of asserting telephony and communication routing patents across multiple jurisdictions.
🛡️ Defendant
A home medical equipment and patient care company relying on automated and intelligent communication systems to manage patient interactions and service delivery.
The Patents at Issue
Five U.S. patents were asserted in this action, all residing in the **intelligent call routing, telephony control, and entity-matching** technology space:
- • US9456086B1 — Intelligent communication routing
- • US10491748B1 — Intelligent communication routing
- • US7269253B1 — Telephony control with intelligent call routing
- • US7023979B1 — Telephony control with intelligent call routing
- • US10237420B1 — Entity matching in auction-based systems
Operating call routing systems?
Check if your communication platform might infringe these or related patents.
The Verdict & Legal Analysis
Outcome
The case terminated via voluntary dismissal without prejudice — initiated unilaterally by Patent Armory Inc. before any substantive court involvement. No damages were awarded. No injunctive relief was issued. No claim construction occurred. The matter is closed at the district court level but remains legally alive: Patent Armory retains the full right to refile these same claims against AdaptHealth or any other defendant in the future.
Legal Significance
Under Rule 41(a)(1)(A)(i), a plaintiff may dismiss an action without a court order if the notice is filed before the opposing party serves an answer or a motion for summary judgment. The key implication: this dismissal required no judicial blessing and carries no res judicata effect. Patent Armory’s claims against AdaptHealth survive intact. This highlights the strategic use of complaint filing to initiate or pressure licensing negotiations.
Filing a telephony patent?
Learn from this case. Use AI to draft stronger claims that can withstand litigation.
Power Your Patent Strategy with Eureka IP
From novelty searches to patent drafting, Eureka’s AI-powered tools help you navigate the patent landscape with confidence.
⚠️ Freedom to Operate (FTO) Analysis
This case highlights critical IP risks in **intelligent call routing and telephony control systems**. Choose your next step:
📋 Understand This Case’s Impact
Learn about the specific risks and implications from this litigation.
- View all related telephony and communication routing patents
- See which NPEs are active in this space
- Understand assertion patterns
🔍 Check My Product’s Risk
Run a comprehensive FTO analysis for your own technology or product.
- Input your communication system description or technical features
- AI identifies potentially blocking patents
- Get actionable risk assessment report
High Risk Area
Intelligent call routing, IVR, telephony control
5 Asserted Patents
In telephony communication space
Design-Around Options
Available for most claims
✅ Key Takeaways
For Patent Attorneys & Litigators
Rule 41(a)(1)(A)(i) dismissals preserve full plaintiff optionality — treat closed NPE cases as deferred, not resolved.
Search related case law →Multi-patent portfolios covering successive generations of a technology create layered assertion leverage.
Explore precedents →For R&D Leaders
Any organization deploying automated call routing, patient communication platforms, or telephony control systems should conduct FTO analysis against Patent Armory’s portfolio.
Start FTO analysis for my product →FTO clearance for communication platform deployments should encompass early-2000s through mid-2010s USPTO grant periods.
Try AI patent drafting →Ready to Strengthen Your Patent Strategy?
Join thousands of IP professionals using Eureka to conduct prior art searches, draft patents, and analyze competitive landscapes.